2021 UNIVERSAL REGISTRATION DOCUMENT

HISTORY OF THE STOCK OPTIONS GRANTED TO MR JEAN-PAUL AGON SINCE HIS APPOINTMENT AS A CORPORATE OFFICER THAT CAN STILL BE EXERCISED AT 31 DECEMBER 2021

N/A.

TABLE OF SHARE SUBSCRIPTION OR PURCHASE OPTIONS EXERCISED BY MR JEAN-PAUL AGON DURING THE 2021 FINANCIAL YEAR

N/A.

HISTORY OF CONDITIONAL GRANTS OF SHARES (ACAS) TO MR JEAN-PAUL AGON SINCE HIS APPOINTMENT AS A CORPORATE OFFICER

Grant date	Number of ACAs granted	Performance conditions⁽³⁾	Grant value (IFRS fair value)	Date of final vesting of all or part of the ACAs	Number of finally vested shares	First possible date of sale of a portion of these⁽⁴⁾
17 April 2012⁽¹⁾	50,000	Yes	3,853,500	18 April 2016	50,000	18 April 2018
26 April 2013⁽¹⁾	40,000	Yes	4,494,800	27 April 2017	40,000	27 April 2019
17 April 2014⁽¹⁾	40,000	Yes	4,183,200	18 April 2018	40,000	18 April 2020
22 April 2015⁽¹⁾	32,000	Yes	5,167,680	23 April 2019	26,432	23 April 2021
20 April 2016⁽²⁾	32,000	Yes	4,938,240	21 April 2020	32,000	21 April 2020
20 April 2017⁽²⁾	32,000	Yes	5,340,800	21 April 2021	26,544	21 April 2021
17 April 2018⁽²⁾	30,000	Yes	5,285,100	18 April 2022	30,000	18 April 2022
18 April 2019⁽²⁾	24,000	Yes	5,430,000	19 April 2023	N/A	19 April 2023

(1) At the end of the vesting period, Mr Jean-Paul Agon, as a French resident on the date of granting the shares, is required to hold the fully vested shares for an additional two-year period during which the shares may not be transferred.

(2) The 20 April 2016, 20 April 2017, 17 April 2018 and 18 April 2019 Plans set a four-year vesting period, without any holding period.

(3) See the performance conditions described in chapter 7 of this document.

(4) Mr Jean-Paul Agon, as corporate officer, shall retain 50% of the fully vested shares in registered form until the end of his duties. Mr Jean-Paul Agon has undertaken not to enter into any risk hedging transactions.

TABLE OF PERFORMANCE SHARES THAT BECAME AVAILABLE DURING THE 2021 FINANCIAL YEAR FOR MR JEAN-PAUL AGON

Grant date	Number of fully vested shares	Grant value (IFRS fair value)	Date of final vesting of all or part of the ACAs	First possible date of sale of a portion of these
17 April 2014⁽¹⁾	17 April 2014 ⁽¹⁾Number of fully vested shares 40,000	17 April 2014 ⁽¹⁾Grant value (IFRS fair value) 4,183,200	17 April 2014 ⁽¹⁾Date of final vesting of all or part of the ACAs 18 April 2018	17 April 2014 ⁽¹⁾First possible date of sale of a portion of these 18 April 2020
20 April 2016⁽¹⁾	20 April 2016⁽¹⁾Number of fully vested shares 32,000	20 April 2016⁽¹⁾Grant value (IFRS fair value) 4,938,240	20 April 2016⁽¹⁾Date of final vesting of all or part of the ACAs 21 April 2020	20 April 2016⁽¹⁾First possible date of sale of a portion of these 21 April 2020
20 April 2017⁽¹⁾	20 April 2017⁽¹⁾Number of fully vested shares 26,544	20 April 2017⁽¹⁾Grant value (IFRS fair value) 4,430,194	20 April 2017⁽¹⁾Date of final vesting of all or part of the ACAs21 April 2021	20 April 2017⁽¹⁾First possible date of sale of a portion of these21 April 2021

(1) Mr Jean-Paul Agon, as corporate officer, shall retain 50% of the fully vested shares in registered form until the end of his duties. Mr Jean-Paul Agon has undertaken not to enter into any risk hedging transactions.

2.4.5. Summary table of the remuneration of Mr Jean-Paul Agon, Chairman of the Board of Directors from 1 May 2021

	2021
In €	Amounts allocated	Amounts paid
Fixed remuneration	1,066,666	1,066,666
Annual variable remuneration	-	-
Exceptional remuneration	-	-
Remuneration for term of office as Director	-	-
Benefits in kind	-	-
TOTAL	1,066,666	1,066,666